Raschi, E.; Poluzzi, E.; Marchesini, G.; De Ponti, F., Dapagliflozin and cardiovascular outcomes: anything else to DECLARE?, «EXPERT OPINION ON PHARMACOTHERAPY», 2019, 20, pp. 1087 - 1090 [articolo]Open Access
Raschi, Emanuel*; Fertonani Affini, Lorenzo; Antonazzo, Ippazio Cosimo; Diemberger, Igor; Poluzzi, Elisabetta; De Ponti, Fabrizio, Drug-induced Kounis syndrome: A matter of pharmacovigilance, «INTERNATIONAL JOURNAL OF CARDIOLOGY», 2019, 274, pp. 381 - 381 [replica/breve intervento]
Raschi, Emanuel; Moretti, Ugo; Salvo, Francesco; Pariente, Antoine; Cosimo Antonazzo, Ippazio; De Ponti, Fabrizio; Poluzzi, Elisabetta, Evolving Roles of Spontaneous Reporting Systems to Assess and Monitor Drug Safety, in: Pharmacovigilance, Gujarat, Charmy S. Kothari, 2019, pp. 1 - 28 [capitolo di libro]
Dothel G.; Bernardini C.; Zannoni A.; Spirito M.R.; Salaroli R.; Bacci M.L.; Forni M.; De Ponti F., Ex vivo effect of vascular wall stromal cells secretome on enteric ganglia, «WORLD JOURNAL OF GASTROENTEROLOGY», 2019, 25, pp. 4892 - 4903 [articolo]Open Access
Ippazio Cosimo Antonazzo; Elisabetta Poluzzi; Emanuele Forcesi; Trond Riise; Kjetil Bjornevik; Elisa Baldin; Luigi Muratori; Fabrizio De Ponti; Emanuel Raschi, Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System, «MULTIPLE SCLEROSIS», 2019, 25, pp. 1633 - 1640 [articolo]
Berardi, Lorenzo; Antonazzo, Ippazio Cosimo; Piccinni, Carlo; Raschi, Emanuel; Forcesi, Emanuele; Fioritti, Angelo; Berardi, Domenico; De Ponti, Fabrizio; Piazza, Antonella; Poluzzi, Elisabetta*, Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres, «PLOS ONE», 2019, 14, Article number: e0211938, pp. e1 - e13 [articolo]Open Access
Fadini G.P.; Sarangdhar M.; De Ponti F.; Avogaro A.; Raschi E., Pharmacovigilance assessment of the association between Fournier's gangrene and other severe genital adverse events with SGLT-2 inhibitors, «BMJ OPEN DIABETES RESEARCH AND CARE», 2019, 7, Article number: e000725, pp. 1 - 8 [articolo]Open Access
Gatti, M.; Raschi, E.; De Ponti, F., Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: Insight from a pharmacovigilance study, «BMC PHARMACOLOGY & TOXICOLOGY», 2019, 20, Article number: 65, pp. 1 - 10 [articolo]Open Access
Raschi E, Antonazzo IC, La Placa M, Ardizzoni A, Poluzzi E, De Ponti F., Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System., «THE ONCOLOGIST», 2019, 24, pp. e1228 - e1231 [articolo]
Giuntoli, Lorenzo; Dalmastri, Vittorio*; Cilloni, Nicola; Orsi, Claudio; Stalteri, Lucia; Demelas, Valentina; Giuliani, Giovanni; Gordini, Giovanni; De Ponti, Fabrizio; La Manna, Gaetano, Severe quetiapine voluntary overdose successfully treated with a new hemoperfusion sorbent, «INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS», 2019, 42, pp. 516 - 520 [articolo]
Raschi E.; De Ponti F., Strategies for early prediction and timely recognition of drug-induced liver injury: The case of cyclin-dependent kinase 4/6 inhibitors, «FRONTIERS IN PHARMACOLOGY», 2019, 10, Article number: 1235, pp. 1 - 15 [articolo]Open Access
Raschi, E.; Mazzarella, A.; Antonazzo, I. C.; Bendinelli, N.; Forcesi, E.; Tuccori, M.; Moretti, U.; Poluzzi, E.; De Ponti, F., Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System, «TARGETED ONCOLOGY», 2019, 14, pp. 205 - 221 [articolo]Open Access
Dothel G.; Chang L.; Shih W.; Barbaro R.; Cremon C.; Stanghellini V.; De Ponti F; Mayer E.A.; Barbara G.; Sternini C., µ-opioid receptor, β-endorphin, and cannabinoid receptor-2 are increased in the colonic mucosa of irritable bowel syndrome patients., «NEUROGASTROENTEROLOGY & MOTILITY», 2019, 31, Article number: e13688, pp. 1 - 12 [articolo]
Dothel, Giovanni; Barbaro, Maria Raffaella; Raschi, Emanuel; Barbara, Giovanni; De Ponti, Fabrizio*, Advancements in drug development for diarrhea-predominant irritable bowel syndrome, «EXPERT OPINION ON INVESTIGATIONAL DRUGS», 2018, 27, pp. 251 - 263 [articolo]
Raschi, Emanuel*; Girardi, Anna; Poluzzi, Elisabetta; Forcesi, Emanuele; Menniti-Ippolito, Francesca; Mazzanti, Gabriela; De Ponti, Fabrizio, Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems, «DRUG SAFETY», 2018, 41, pp. 745 - 752 [articolo]
